Silexion Therapeutics Corp

News & Events

Press Releases

In The Media

1. Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers

   GlobeNewswire MAY 29, 2025 9:05 AM EDT
   GRAND CAYMAN, Cayman Islands, May 29, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDA...
   READ ARTICLE

2. Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204's Potential Impact on Colorectal and Lung Cancer

   GlobeNewswire MAY 21, 2025 8:45 AM EDT
   GRAND CAYMAN, Cayman Islands, May 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp (NASDAQ...
   READ ARTICLE

3. Silexion Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

   GlobeNewswire MAY 13, 2025 4:45 PM EDT
   GRAND CAYMAN, Cayman Islands, May 13, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDA...
   READ ARTICLE

4. Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities

   GlobeNewswire APR 23, 2025 9:20 AM EDT
   Grand Cayman, Cayman Islands, April 23, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NAS...
   READ ARTICLE

5. Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data

   GlobeNewswire MAR 28, 2025 8:30 AM EDT
   Grand Cayman, Cayman Islands, March 28, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NAS...
   READ ARTICLE

6. Silexion Therapeutics Announces Completion of Innovative Expanded Development Plan for SIL204 which will be unveiled at the 2025 NeauxCancer Conference

   GlobeNewswire MAR 21, 2025 8:30 AM EDT
   Grand Cayman, Cayman Islands, March 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (&#x...
   READ ARTICLE

7. Silexion Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

   GlobeNewswire MAR 18, 2025 4:29 PM EDT
   Grand Cayman, Cayman Islands, March 18, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NAS...
   READ ARTICLE

8. PESG Report: Silexion Therapeutics' Breakthrough Data Shows SIL204's impact on both Primary Tumors & Metastasis - Signaling a Potential Paradigm Shift in Cancer Treatment

   Business Wire MAR 17, 2025 8:15 AM EDT
   Silexion's Groundbreaking Orthotopic Model Data and the Potential Expansion of its Development Pl...
   READ ARTICLE

9. Silexion Therapeutics Reports Groundbreaking Positive Initial Data from Systemic Administration of SIL204 in Orthotopic Pancreatic Cancer Models

   GlobeNewswire MAR 5, 2025 8:30 AM EST
   Grand Cayman, Cayman Islands, March 05, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NAS...
   READ ARTICLE

10. PESG Industry Update: Anticipation Rises as Silexion Therapeutics Approaches a Key Preclinical Data That Could Be Transformational

    Business Wire MAR 3, 2025 8:30 AM EST
    Silexion Therapeutics approaches a potential key milestone with upcoming orthotopic pancreatic ca...
    READ ARTICLE